The effect of ethnicity and sexual preference on prostate-cancer-related quality of life

Nature Reviews Urology

Volumn 9, Issue 5, 2012, Pages 258-265

  Kleinmann, Nir ^a   Zaorsky, Nicholas G ^a   Showalter, Timothy N ^a   Gomella, Leonard G ^a   Lallas, Costas D ^a   Trabulsi, Edouard J ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ASIAN; ETHNICITY; HIGH RISK PATIENT; HUMAN; MALE; MALE HOMOSEXUAL; MALE SEXUAL DYSFUNCTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL SUPPORT;

ETHNIC GROUPS; HOMOSEXUALITY, MALE; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SEXUAL BEHAVIOR;

EID: 84862232053     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.56     Document Type: Review

References (82)

1. The American Cancer Society. Cancer facts and figures [online], http://www.cancer.org/docroot/STT/stt-0.asp (2012
2. Thompson, I. et al. Guideline for the management of clinically localized prostate cancer: update. J. Urol. 177, 2106-2131 (2007
3. Eton, D. T. & Lepore, S. J. Prostate cancer and health-related quality of life: a review of the literature. Psychooncology 11, 307-326 (2002
4. Penson, D. F., Litwin, M. S. & Aaronson, N. K. Health related quality of life in men with prostate cancer. J. Urol. 169, 1653-1661 (2003
5. Larsen, D. L., Attkisson, C. C., Hargreaves, W. A. & Nguyen, T. D. Assessment of client/patient satisfaction: development of a general scale. Eval. Program Plann. 2, 197-207 (1979
6. Fairclough, D. L. & Cella, D. F. Functional Assessment of Cancer Therapy (FACT-G): non-response to individual questions. Qual. Life Res. 5, 321-329 (1996
7. Webster, K., Cella, D. & Yost, K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual. Life Outcomes 1, 79 (2003
8. Aaronson, N. K. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 85, 365-376 (1993
9. Dipietro, L., Caspersen, C. J., Ostfeld, A. M. & Nadel, E. R. A survey for assessing physical activity among older adults. Med. Sci. Sports Exerc. 25, 628-642 (1993
10. Clarfield, A. M. Teaching public health related to the elderly. Public Health Rev. 30, 271-276 (2002
11. Lawton, B. A. et al. Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial. BMJ 11, 337 (2008
12. Young, D. R., Jee, S. H. & Appel, L. J. A comparison of the Yale Physical Activity Survey with other physical activity measures. Med. Sci. Sports Exerc. 33, 955-961 (2001
13. De Abajo, S., Larriba, R. & Marquez, S. Validity and reliability of the Yale Physical Activity Survey in Spanish elderly. J. Sports Med. Phys. Fitness 41, 479-485 (2001
14. Pennathur, A., Magham, R., Contreras, L. R. & Dowling, W. Test-retest reliability of Yale Physical Activity Survey among older Mexican American adults: a pilot investigation. Exp. Aging Res. 30, 291-303 (2004
15. Buysse, D. J. et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28, 193-213 (1989
16. Delgado-Guay, M. et al. Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J. Pain Symptom Manage. 41, 819-827 (2011
17. Rosen, R. C. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49, 822-830 (1997
18. Hafez, E. S. & Hafez, S. D. Erectile dysfunction: anatomical parameters, etiology, diagnosis, and therapy. Arch. Androl. 51, 15-31 (2005
19. Litwin, M. S. et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med. Care 36, 1002-1012 (1998
20. Gacci, M. et al. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index. Urology 66, 338-343 (2005
21. Korfage, I. J. et al. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Qual. Life Res. 12, 459-464 (2003
22. Singh, J., Trabulsi, E. J. & Gomella, L. G. The quality-of-life impact of prostate cancer treatments. Curr. Urol. Rep. 11, 139-146 (2010
23. Quek, M. L. & Penson, D. F. Quality of life in patients with localized prostate cancer. Urol. Oncol. 23, 208-215 (2005
24. Kakehi, Y. et al. Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite. J. Urol. 177, 1856-1861 (2007
25. Szymanski, K. M., Wei, J. T., Dunn, R. L. & Sanda, M. G. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology 76, 1245-1250 (2010
26. Wei, J. T. et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56, 899-905 (2000
27. van Andel, G. et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur. J. Cancer 44, 2418-2424 (2008
28. Ramsey, S. D. et al. On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J. Urol. 177, 1992-1999 (2007
29. Passel, J. S. Demography of immigrant youth: past, present, and future. Future Child. 21, 19-41 (2011
30. Weir, H. K. et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl Cancer Inst. 95, 1276-1299 (2003
31. Merrill, R. M. & Lyon, J. L. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology 55, 730-735 (2000
32. Ross, L. E., Berkowitz, Z. & Ekwueme, D. U. Use of the prostate-specific antigen test among US men: findings from the National Health Interview Survey. Cancer Epidemiol. Biomarkers Prev. 17, 636-644 (2005
33. Carpenter, W. R. et al. Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control. 21, 1071-1080 (2010
34. Freeman, H. P., Muth, B. J. & Kerner, J. F. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 3, 19-30 (1995
35. Underwood, S. M. Reducing the burden of cancer borne by African Americans: if not now, when? Cancer Epidemiol. Biomarkers Prev. 12, 270s-276s (2003
36. Haiman, C. A. et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat. Genet. 43, 570-573 (2011
37. Rishi, I. et al. Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl. Immunohistochem. Mol. Morphol. 11, 253-260 (2003
38. Farkas, A. et al. National trends in the epidemiology of prostate cancer, to 1973-1994: evidence for the effectiveness of prostate-specific antigen screening. Urology 52, 444-449 (1998
39. Chornokur, G., Dalton, K., Borysova, M. E. & Kumar, N. B. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate 71, 985-997 (2011
40. Halbert, C. H. et al. Racial differences in quality of life following prostate cancer diagnosis. Urology 76, 559-564 (2010
41. Jayadevappa, R. et al. Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients. Cancer 109, 2229-2238 (2007
42. Do, Y. K. et al. Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control. 21, 31-40 (2010
43. Cohen, J. H. et al. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes Control. 17, 803-811 (2006
44. Rice, K. et al. Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic. Urology 76, 1231-1238 (2010
45. Moses, K. A. et al. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J. Clin. Oncol. 28, 1069-1074 (2010
46. Eton, D. T., Lepore, S. J. & Helgeson, V. S. Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer 92, 1451-1459 (2001
47. Stanford, J. L. et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 283, 354-360 (2000
48. Penedo, F. J. et al. Ethnicity and determinants of quality of life after prostate cancer treatment. Urology 67, 1022-1027 (2006
49. Garofalo, J. P., Hamann, H. A., Ashworth, K. & Baum, A. Stress and quality of life in African American cancer survivors. Ethn. Dis. 16, 732-738 (2006
50. Yamoah, K., Stone, N. & Stock, R. Impact of race on biochemical disease recurrence after prostate brachytherapy. Cancer 117, 5589-5600 (2011
51. Penedo, F. J. et al. A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann. Behav. Med. 31, 261-270 (2006
52. Haas, J. S. et al. Lower use of hospice by cancer patients who live in minority versus white areas. J. Gen. Intern. Med. 22, 396-399 (2007
53. Smith, A. K., Earle, C. C. & McCarthy, E. P. Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J. Am. Geriatr. Soc. 57, 153-158 (2009
54. Williams, H. & Powell, I. J. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol. Biol. 472, 439-453 (2009
55. Zhang, L. et al. Prostate cancer: an emerging threat to the health of aging men in Asia. Asian J. Androl. 13, 574-578 (2011
56. Nakazato, H. et al. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br. J. Cancer 89, 691-696 (2003
57. Xu, B. et al. ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies. Prostate Cancer Prostatic Dis. 13, 270-277 (2010
58. Wei, B. et al. XRCC1 Arg399Gln and ArgXXXXX194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis. 14, 225-231 (2011
59. Raymundo, E. M. et al. Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system. BJU Int. 107, 1216-1222 (2011
60. Yoon, D. K. et al. Can the prostate risk calculator based on western population be applied to Asian population? Prostate http://dx.doi.org/10.1002/ pros.21475.
61. Namiki, S. et al. Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men. Prostate Cancer Prostatic Dis. 12, 67-71 (2009
62. Black, D., Gates, G., Sanders, S. & Taylor, L. Demographics of the gay and lesbian population in the United States: evidence from available systematic data sources. Demography 37, 139-154 (2000
63. Laumann, E. O., Michael, R. T. & Gagnon, J. H. A political history of the national sex survey of adults. Fam. Plann. Perspect. 26, 34-38 (1994
64. Blank, T. O. Gay men and prostate cancer: invisible diversity. J. Clin. Oncol. 23, 2593-2596 (2005
65. Mitteldorf, D. in A Gay Man's Guide to Prostate Cancer (eds Perlman, G. & Drescher J.) Ch. Psychotherapy with gay prostate cancer patients 57-67 (Haworth Medical Press, Binghamton, NY, 2005
66. Cornell, D. in A Gay Man's Guide to Prostate Cancer (eds Perlman, G. & Drescher J.) Ch. A gay urologist's changing views of prostate cancer 29-41 (Haworth Medical Press, Binghamton, NY, 2005
67. Latini, D. M. et al. Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J. Urol. 168, 2086-2091 (2002
68. Kedia, S. et al. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer. Urology 54, 308-312 (1999
69. Litwin, M. S., Melmed, G. Y. & Nakazon, T. Life after radical prostatectomy: a longitudinal study. J. Urol. 166, 587-592 (2001
70. Schover, L. R. et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 95, 1773-1785 (2002
71. Fergus, K. D., Gray, R. E. & Fitch, M. I. Sexual dysfunction and the preservation of manhood: experiences of men with prostate cancer. J. Health Psychol. 7, 303-316 (2002
72. Berger, R. M. Gay and Gray: the Older Homosexual Man. (University of Illinois Press, Urbana, IL, 1982
73. McWhirter, D. P. & Mattison, A. M. Psychotherapy for gay male couples. J. Homosex. 7, 79-91 (1981
74. Motofei, I. G. et al. Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal. BJU Int. 108, 110-115 (2011
75. Savic, I., Berglund, H. & Lindstrom, P. Brain response to putative pheromones in homosexual men. Proc. Natl Acad. Sci. USA 102, 7356-7361 (2005
76. Yeh, K. Y. et al. Different subregions of the medial preoptic area are separately involved in the regulation of copulation and sexual incentive motivation in male rats: a behavioral and morphological study. Behav. Brain Res. 205, 219-225 (2009
77. Savic, D. & Jelic, S. A theoretical study of hypothalamo-pituitary- adrenocortical axis dynamics. Ann. NY Acad. Sci. 1048, 430-432 (2005
78. Berglund, H., Lindstrom, P. & Savic, I. Brain response to putative pheromones in lesbian women. Proc. Natl Acad. Sci. USA 103, 8269-8274 (2006
79. Hart, S., Coon, D., Kowalkowski, M. & Latini, D. Gay men with prostate cancer report significantly worse HRQoL than heterosexual men. Moderated poster no. 163. Presented at the 2011 American Urological Association Annual Meeting. Washington, DC, USA.
80. Wainrib, B. R., Maguire, J. & Haber, S. Men, Women, and Prostate Cancer: a Medical and Psychological Guide for the Women and the Men they Love. (New Harbinger Publications, Oakland, CA, 2000
81. Namiki, M. et al. Prostate Cancer Working Group report. Jpn J. Clin. Oncol. 40 (Suppl. 1), 70-75 (2010
82. Sim, H. G. & Cheng, C. W. Changing demography of prostate cancer in Asia. Eur. J. Cancer 41, 834-845 (2005)